Search Results - Pierre Michel Llorca

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review by Ludivine Boudieu, Myriam Mennetrier, Pierre-Michel Llorca, Ludovic Samalin

Connect to this object online.

Health related quality of life in patients having schizophrenia negative symptoms - a systematic review by Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre-Michel Llorca, Mondher Toumi

Connect to this object online.

Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes by Katalin Pungor, Vasilis P. Bozikas, Robin Emsley, Pierre-Michel Llorca, Srihari Gopal, Maju Mathews, Annette Wooller, Paul Bergmans

Connect to this object online.

Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases by Maëlys Touya, François-Xavier Lamy, Adrian Tanasescu, Delphine Saragoussi, Clément François, Alan G. Wade, Pierre-Michel Llorca, Christophe Lançon, Bruno Falissard

Connect to this object online.

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting by Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu, Mondher Toumi

Connect to this object online.

Results and validation of an index to measure health state of patients with depression in automated healthcare databases by François-Xavier Lamy, Bruno Falissard, Clément François, Christophe Lançon, Pierre Michel Llorca, Adrian Tanasescu, Maëlys Touya, Patrice Verpillat, Alan G. Wade, Delphine Saragoussi

Connect to this object online.

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia by Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Katalin Pungor

Connect to this object online.

Poverty and inequality in real-world schizophrenia: a national study by Guillaume B. Fond, Guillaume B. Fond, Dong Keon Yon, Dong Keon Yon, Bach Tran, Bach Tran, Jasmina Mallet, Jasmina Mallet, Mathieu Urbach, Mathieu Urbach, Sylvain Leignier, Sylvain Leignier, Romain Rey, Romain Rey, David Misdrahi, David Misdrahi, David Misdrahi, Pierre-Michel Llorca, Pierre-Michel Llorca, Franck Schürhoff, Franck Schürhoff, Fabrice Berna, Fabrice Berna, Laurent Boyer, Laurent Boyer

Connect to this object online.

Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology by Clément François, Adrian Tanasescu, François-Xavier Lamy, Nicolas Despiegel, Bruno Falissard, Ylana Chalem, Christophe Lançon, Pierre-Michel Llorca, Delphine Saragoussi, Patrice Verpillat, Alan G. Wade, Djamel A. Zighed

Connect to this object online.

End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database by Guillaume Fond, MD, Sebastien Salas, ProfMD, Vanessa Pauly, PhD, Karine Baumstarck, MD, Cecile Bernard, MD, Veronica Orleans, MSc, Pierre-Michel Llorca, ProfMD, Christophe Lancon, ProfMD, Pascal Auquier, ProfMD, Laurent Boyer, ProfMD

Connect to this object online.

Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) by Célia Lloret-Linares, Youssef Daali, Sylvie Chevret, Isabelle Nieto, Fanny Molière, Philippe Courtet, Florence Galtier, Raphaëlle-Marie Richieri, Sophie Morange, Pierre-Michel Llorca, Wissam El-Hage, Thomas Desmidt, Frédéric Haesebaert, Philippe Vignaud, Jerôme Holtzmann, Jean-Luc Cracowski, Marion Leboyer, Antoine Yrondi, Fabienne Calvas, Liova Yon, Philippe Le Corvoisier, Olivier Doumy, Kyle Heron, Damien Montange, Siamak Davani, Julien Déglon, Marie Besson, Jules Desmeules, Emmanuel Haffen, Frank Bellivier

Connect to this object online.

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort by Nathan Vidal, Nathan Vidal, Paul Roux, Paul Roux, Mathieu Urbach, Mathieu Urbach, Cristobal Belmonte, Cristobal Belmonte, Laurent Boyer, Laurent Boyer, Delphine Capdevielle, Delphine Capdevielle, Delphine Capdevielle, Julie Clauss-Kobayashi, Julie Clauss-Kobayashi, Thierry D'Amato, Thierry D'Amato, Romane Dassing, Romane Dassing, Caroline Dubertret, Caroline Dubertret, Julien Dubreucq, Julien Dubreucq, Guillaume Fond, Guillaume Fond, Roxana-Mihaela Honciuc, Roxana-Mihaela Honciuc, Sylvain Leignier, Sylvain Leignier, Pierre-Michel Llorca, Pierre-Michel Llorca, Jasmina Mallet, Jasmina Mallet, David Misdrahi, David Misdrahi, Baptiste Pignon, Baptiste Pignon, Romain Rey, Romain Rey, Franck Schürhoff, Franck Schürhoff, Arnaud Tessier, Arnaud Tessier, the FACE-SZ (FondaMental Academic Centers of Expertise-Schizophrenia), Christine Passerieux, Christine Passerieux, Eric Brunet-Gouet, Eric Brunet-Gouet, B. Aouizerate, V. Barteau, S. Bensalem, F. Berna, O. Blanc, E. Bourguignon, L. Boyer, D. CapdevielleI. Chéreau, G. Chesnoy-Servanin, T. D'Amato, A. Deloge, H. Denizot, JM. Dorey, C. Dubertret, J. Dubreucq, S. Esselin, C. Faget, C. Fluttaz, G. Fond, F. Gabayet, O. Godin, E. Haffen, RM. Honciuc, M. Jarroir, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, PM Llorca, J. Mallet, E. Metairie, D. Misdrahi, C. Passerieux, J. Petrucci, P. Peri, B. Pignon, S. Pires, C. Portalier, R. Rey, C. Roman, F. Schürhoff, K. Souryis, A. Szöke, M. Urbach, F. Vaillant, A, Vehier, P. Vidailhet, E. Vilà, G. Wahiche, H. Yazbek, A. Zinetti-Bertschy

Connect to this object online.